Company: NIVFW
Filing Date: 2025-08-21
Form Type: DRS
Source: 0001213900-25-079301
Chunk: 65

Company: NewGenIvf Group Ltd
Filing Date: 2025-08-21
Form: DRS
Chunk 65
---
 Bank of Thailand, which is the central bank of Thailand, is responsible for formulating and implementing monetary
policies in the country to maintain the price stability and promote economic stability and sustainable growth. The Bank of Thailand imposes
(four) measures in preventing THB fluctuation. Those are measures to limit THB liquidity, to curb capital inflows, to limit the flows
on Non-resident Bank Account and Non-resident Baht for Securities, and to limit the flows on Non-Deliverable Forward transactions. With
an increased floating range of the THB’s value against foreign currencies and a more market-oriented mechanism for determining the
mid-point exchange rates, the THB may further appreciate or depreciate significantly in value against the U.S. dollar or other foreign
currencies in the long-term, depending on the fluctuation of the basket of currencies against which it is currently valued, or it may
be permitted to enter into a full float, which may also result in a significant appreciation or depreciation of the THB against the U.S. dollar
or other foreign currencies. It cannot be assured that THB will not experience significant appreciation or depreciation against the U.S. dollar
or other foreign currencies in the future.

Furthermore, NewGenIvf is
also currently required to obtain approvals before converting significant sums of foreign currencies into THB. All of these factors could
materially and adversely affect its business, results of operations, financial condition and prospects, and could reduce the value of,
and dividends payable on, its shares in foreign currency terms.

Sales of a substantial number of our securities in the public market could cause the price of our Ordinary Shares to decrease significantly.

Sales of substantial amounts
of the Class A Ordinary Shares in the public market after the completion of this offering, or the perception that these sales could occur,
could adversely affect the market price of the Class A Ordinary Shares and materially impair our ability to raise capital through equity
offerings in the future. The Class A Ordinary Shares sold in this offering will be freely tradable without restriction or further registration
under the Securities Act, and shares held by our existing shareholders may also be sold in the public market in the future subject to
the restrictions in Rule 144 and Rule 701 under the Securities Act and the applicable lock-up agreements, if any. We cannot predict what
effect, if any, market sales of securities held by our significant shareholders or any other shareholder or the availability of these
securities for future sale will have on the market price of the